Reassuring Data on Two-Dose Hep B Vaccine, Risk of Acute MI
(MedPage Today) -- There was no higher risk of heart attack for recipients of the two-dose hepatitis B cytosine phosphoguanine adjuvant vaccine (Heplisav-B) compared to the three-dose hepatitis B vaccine with an aluminum hydroxide adjuvant (Engerix...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news
More News: Cardiology | Gastroenterology | Heart | Heart Attack | Hepatitis | Hepatitis B | Hepatitis Vaccine | Vaccines